Valuation: Camurus AB

Market Cap 39.87B 4.02B 3.61B 3.33B 3.02B 5.64B 383B 5.71B 15.88B 200B 15.09B 14.77B 636B P/E 2026 *
42.2x
P/E 2027 * 28.3x
Enterprise Value 35.39B 3.57B 3.2B 2.96B 2.68B 5.01B 340B 5.07B 14.09B 178B 13.39B 13.11B 565B EV / Sales 2026 *
12.4x
EV / Sales 2027 * 9.17x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+1.06%
Current month+7.29%
1 month+6.26%
3 months+7.46%
6 months+27.62%
Current year+8.77%
1 week 657
Extreme 657
680.5
1 month 608
Extreme 608
680.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
710
3 years 323.6
Extreme 323.6
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
7/8/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/2/26 Sell

Chief Executive Officer

55,550 0.0928%
27/2/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%0.00%+8.94%+106.15% 3.97B
+0.50%+1.38%+57.09%+129.96% 1,143B
+0.86%+5.14%+45.00%+86.15% 647B
-0.14%+0.42%+25.69%+105.85% 506B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 350B
+0.34%+1.84%+30.70%+54.27% 293B
-0.45%+1.19%+2.89%+26.08% 265B
+0.87%+3.08%+54.69%+72.74% 242B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.24%+1.29%+37.47%+79.38% 403.15B
Weighted average by Cap. +0.26%+1.55%+44.46%+89.03%

Financials

2026 *2027 *
Net sales 2.85B 288M 258M 239M 216M 404M 27.41B 409M 1.14B 14.34B 1.08B 1.06B 45.53B 3.73B 376M 337M 312M 282M 527M 35.78B 534M 1.48B 18.72B 1.41B 1.38B 59.44B
Net income 948M 95.6M 85.77M 79.3M 71.82M 134M 9.1B 136M 378M 4.76B 359M 351M 15.12B 1.42B 143M 128M 118M 107M 200M 13.6B 203M 564M 7.12B 536M 524M 22.59B
Net Debt -4.49B -452M -406M -375M -340M -635M -43.07B -642M -1.79B -22.54B -1.7B -1.66B -71.55B -5.7B -575M -516M -477M -432M -807M -54.78B -817M -2.27B -28.67B -2.16B -2.11B -91.01B
Projected Income Statement - Annual - Camurus AB
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
28/10/26 SEK 670.00 +1.06% 93,277
27/10/26 SEK 663.00 -0.67% 73,992
26/10/26 SEK 667.50 +0.23% 50,306
23/10/26 SEK 666.00 -0.52% 49,592
22/10/26 SEK 669.50 -0.07% 78,976
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Camurus AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
670.00SEK
Average target price
807.25SEK
Spread / Average Target
+20.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camurus AB
  1. Stock Market
  2. Stocks
  3. CAMX Stock